|
FDA Removes from Market Unapproved Cough and Cold Prescription Products
|
|
|
| By
Angie Drakulich
|
|
|
|
FDA announced on Mar. 2, 2011, that it is taking action against companies that manufacture, distribute, or market certain unapproved prescription oral cough, cold, and allergy products, according to an agency release.
|
|
|
|
FDA Sends sanofi aventis Two Warning Letters
|
|
|
| By
Erik Greb
|
|
|
|
FDA recently sent sanofi-aventis two Warning Letters for its facilities in Frankfurt am Main, Germany, and Bridgewater, NJ.
|
|
|
|
Merck Sells Contract Biopharmaceutical Business to Fujifilm
|
|
|
| By
Patricia Van Arnum
|
|
|
|
Fujifilm and Merck & Co. have formed a definitive agreement by which Fujifilm will acquire the Merck BioManufacturing Network, a contract biopharmaceutical manufacturing and development business of Merck.
|
|
|
|
EU–India FTA Dispute Continues
|
|
|
| By
Stephanie Sutton
|
|
|
|
Ongoing Free Trade Agreement (FTA) negotiations between the EU and India have hit a hurdle as some stakeholders urge the Indian government to fight against certain provisions in the FTA amid fears that access to generic drugs may be affected.
|
|
|
|
EMA Challenged Over Conflict-of-Interest Case
|
|
|
| By
Stephanie Sutton
|
|
|
|
A number of European public health and transparency campaigners believe that conflict of interest rules may have been breached with the EMA's decision to allow its former Executive Director, Thomas Lönngren, to take up an advisory role within the private pharmaceutical sector.
|
|
|
|
Rare Disease Day 2011 – "Rare but Equal"
|
|
|
| By
Rich Whitworth
|
|
|
|
The European Organization for Rare Diseases (EURORDIS), an alliance of patient organizations and individuals, celebrated its fourth Rare Disease Day on February 28.
|
|
|
|
Week of Feb. 28, 2011: Company and People Notes: Pfizer Completes King Acquisition; ViiV Healthcare Names Chairman; and More.
|
|
|
|
Pfizer Completes King Acquisition; ViiV Healthcare Names Chairman; and More.
|
|
|
|
Regulatory Roundup: FDA and Georgetown University Form Innovation Partnership
|
|
|
|
FDA and Georgetown University Form Innovation Partnership
|
|
|
